Ensuring Patient Access and Effective Drug Enforcement Act of 2014
Committee's #RecordofSuccess Grows With Three More Bipartisan Bills Passed By the House
Pitts, Pallone Introduce Bipartisan Legislation to Crack Down on Anabolic Steroids
Letter to Margaret Hamburg, Commissioner of US Food and Drug Administration - Committee Presses FDA for Documents On Trial Lawyers' Role in Proposed Changes to Generic Drug Labeling
Hearing of the Health Subcommittee of the House Energy and Commerce Committee - Examining the Implementation of the Tobacco Control Act
Hearing of Health Subcommittee of the House Energy and Commerce Committee - Improving Predictability and Transparency in DEA and FDA Regulation
Pitts, Pallone Introduce Legislation to Speed New Therapies
GOP Senate, House Lawmaker Inquiry Reveals Weak Administration Oversight of Drug Discount Program for Uninsured, Low-Income Americans
Health Subcommittee Continues Examination of Drug Compounding
Hearing of the House Health Subcommittee of the Energy and Commerce Committee - Reforming the Drug Compounding Regulatory Framework
Hearing of the House Health Subcommittee of the Energy and Commerce Committee - "Examining the Federal Government's Response to the Prescription Drug Abuse Crisis"
Pitts, Schakowsky, Whitfield and Eshoo Introduce Bill to End Doping of Racehorses
Letter to U.S. Secretary of State John Kerry - U.S.-Colombia Policy
Food and Drug Administration Safety and Innovation Act
Food and Drug Administration Reform Act of 2012
Racing Out of Control
Hearing of the Health Subcommittee of the House Energy and Commerce Committee - "FDA User Fees 2012: Hearing on Issues Related to Accelerated Approval, Medical Gas, Antibiotic Development and Downstream Pharmaceutical Supply Chain
Grassley, Enzi, Hatch, Pitts Seek Details of Discount Drug Program
Members Introduce Bipartisan Legislation to Improve FDA Generic Drug Approvals
Hearing of the Health Subcommittee of the House Energy and Commerce Committee - Review of the Proposed Generic Drug and Biosimilars User Fees and Further Examination of Drug Shortages
Hearing of the Health Subcommittee of the House Energy and Commerce Committee - Reauthorization of PDUFA: What It Means for Jobs, Innovation, and Patients
Synthetic Drug Control Act of 2011
Congress Has Not Been Waiting to Combat Drug Shortages
Ongoing Investigation Reveals Chinese Firms Linked to Contaminated Heparin Still Supplying Crude Heparin to U.S.
Investigation Shows Chinese Firms Linked to Contaminated Drugs Still Supplying the U.S.
Hearing of the Health Subcommittee of the House Energy and Commerce Committee - "Examining the Increase in Drug Shortages"
Hearing of the Health Subcommittee of the House Energy and Commerce Committee - Legislative Hearing to Address Bioterrorism, Controlled Substances and Public Health Issues
Health Subcommittee Examines FDA Regulatory Process
Leading House Republicans Decry FDA Move on Breast Cancer Drug as a First Step Towards Rationing Care
Memorandum on Health Care Reform Legislation
Hearing Of The Health Subcommittee Of The House Committee On Energy And Commerce - Comprehensive Health Reform Discussion Draft, Day Three
Hearing Of The Health Subcommittee Of The House Energy And Commerce Committee - Emerging Health Care Issues: Follow-On Biologic Drug Competition
Panel I of a Hearing of the Health Subcommittee of the House Energy and Commerce Committee - Drug Safety Provisions of the Food and Drug Administration Globalization Act Discussion Draft Legislation
Time to Enforce Internet Gambling Laws
The Friday Faxline (Issue 475, September 22, 2006)
Time For Changes At The UN
Floor Speech - Medicare Drug Discount Cards
Drug Discount Cards
Doing What's Right for Pennsylvania's Seniors
What changes can you expect to Medicare?